Literature DB >> 6809788

Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.

A L Barry, R N Jones, C Thornsberry, T L Gavan.   

Abstract

A nine-laboratory coordinated study was performed to establish tentative control limits for 75-mu g azlocillin disks tested against the standard control strain of Pseudomonas aeruginosa (ATCC 27853). Control limits for individual tests were 24 to 30 mm (25 to 29 mm for means of five separate tests). To establish interpretive zone standards for 75-mu g azlocillin disks, three separate laboratories each tested 93 strains of P. aeruginosa or related species. Geometric mean minimal inhibitory concentrations (MICs) were plotted against arithmetic mean zone diameters. Regression analyses were performed with zone diameter as the independent variable and also with MIC as the independent variable. The following interpretive categories were recommended: resistant, less than or equal to 14 mm (MIC, greater than 128 mu g/ml); intermediate, 15 to 17 mm (MIC, 128 mu g/ml); and susceptible, greater than or equal to 18 mm (MIC, less than or equal to 64 mu g/ml).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809788      PMCID: PMC272309          DOI: 10.1128/jcm.16.1.135-140.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Authors:  T L Gavan; R N Jones; A L Barry; P C Fuchs; E H Gerlach; J M Matsen; L B Reller; C Thornsberry; L D Thrupp
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

4.  In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

Authors:  A L Barry; C Thornsberry; R N Jones; T L Gavan
Journal:  Cleve Clin Q       Date:  1980

5.  Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.

Authors:  R Wise; A P Gillett; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

6.  Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.

Authors:  L Coppens; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Azlocillin and mezlocillin: new ureido penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.

Authors:  A L Barry; R N Jones; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

  8 in total
  4 in total

1.  Interpretive criteria for the agar diffusion susceptibility test with ofloxacin.

Authors:  H Grimm
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.

Authors:  A L Barry; G H Miller; R S Hare; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

3.  Quality control of moxalactam susceptibility disks.

Authors:  A L Barry; D A Preston; R N Jones; T L Gavan; C Thornsberry
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

4.  Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.

Authors:  G Kronvall
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.